A crucial element of regenerative medicine and drug discovery lies in the ability to grow human stem cell groups to sufficient quantities for therapeutic uses. Traditionally, limited cell supply posed a significant barrier to progress in these fields. Consequently, considerable work has been directed towards enhancing protocols for stem cell growth